Tags: life sciences

OpenAI unveiled GPT‑Rosalind, its first large‑language model built specifically for life‑science research. Named for DNA pioneer Rosalind Franklin, the system is designed to help scientists sort through massive data sets, generate hypotheses and speed the development of new medicines. OpenAI says the model can cut the 10‑ to 15‑year timeline typical for U.S. drug approval by improving target selection and experiment design. Available now as a research preview through a trusted‑access platform, GPT‑Rosalind also includes safeguards against misuse, as the company faces a copyright lawsuit from Ziff Davis. Ler mais

OpenAI has unveiled GPT‑Rosalind, a large language model tuned specifically for biology. The new system aims to curb the over‑enthusiasm and sycophancy that have plagued earlier models, offering more skeptical, fact‑checked responses on drug targets and other scientific queries. Access is restricted to U.S. entities through a trusted‑deployment program, with a broader Life Sciences Research Plugin slated for later release. OpenAI cites safety concerns, including the risk of the model being used to optimize harmful viruses, as the reason for the limited rollout. Ler mais

Anthropic completed a $400 million stock purchase of Coefficient Bio, a stealth AI biotech firm founded by former Genentech researchers Samuel Stanton and Nathan C. Frey. The acquisition adds a ten‑person team focused on accelerating drug discovery to Anthropic’s health and life‑science division, following the company’s October launch of Claude for Life Sciences, an AI tool aimed at scientific research. Ler mais

The nonprofit that controls OpenAI, now called the OpenAI Foundation, announced a plan to invest at least $1 billion in its four new program areas—life sciences, jobs and economic impact, AI resilience, and community initiatives. The commitment is described as the first tranche of a larger $25 billion pledge linked to the foundation’s equity stake following the 2023 recapitalisation that valued the for‑profit arm at roughly $130 billion. New senior hires will lead the expanded grantmaking effort, marking a dramatic shift from a $7.6 million grantmaker in 2024 to a major philanthropic player. Ler mais

Runway announced its new GWM-1 "world model" technology, asserting it can maintain coherent output for minutes at a time. The company framed the model as a step toward unifying diverse domains and action spaces under a single base system. While highlighting potential uses in film, television, advertising, robotics, physics and life‑science research, Runway also disclosed a partnership with CoreWeave that will employ Nvidia GB300 NVL72 racks for training and inference. The move positions Runway in a competitive AI arena where larger tech firms also pursue similar capabilities. Ler mais

The UK government unveiled a $130 million plan to buy artificial‑intelligence technology as part of a broader AI package aimed at strengthening the nation’s life‑science, financial, defence and creative sectors. Labour officials say the initiative will upgrade tech infrastructure, attract investment from U.S. firms such as OpenAI and Anthropic, and signal strong political backing ahead of the upcoming budget. Strategic partnerships with American groups will bring talent and infrastructure to the public sector, while a new sovereign AI fund, chaired by Balderton venture capitalist James Wise, will support startups alongside the British Business Bank. Ler mais